Stand out for this role — generate a tailored resume and cover letter in about a minute.
CH01 CHE Fresenius Medical Care (Schweiz) AG is seeking an ATR Supervisor to oversee accounting, reporting and closing for GL, intercompany and fixed assets in a hybrid setting. You will supervise the team, ensure timely deliverables, and support migration and process improvements across the ATR function.
The role requires a Bachelor’s in Accounting/Finance and a CPA license is preferred, with 3+ years supervisory experience in ATR or related areas.
Hybrid - Upon agreement between you and your supervisor, you are entitled to a flexible arrangement where you will be able to split your time between working from the office and working remotely. The Account to Report (ATR) Supervisor will be responsible for the delivery of work of a certain cluster or sub-team under the Account to Report (ATR) function within the established policy and agreed service level. The cluster or sub-team can be a group of countries/entities &/or sub- processes under ATR. The Supervisor will be working under the direction of the ATR Manager.
Graduate of Bachelor's degree preferred in Accounting or Finance Certified Public Accountant (CPA) license preferred Finance and Accounting Experience with solid exposure in:
Had previous exposure in handling and managing transitions and/or projects for process improvement
At least three (3) years in a supervisory role focused on the ATR function With proven results and past successes in crisis management, process improvements, stakeholder management and business partnering
Proficient in using MS Office product With 5 to 8 years working experience in Account to Report Minimum three (3) years working knowledge in SAP or any ERP system Experience in Shared Services Center/BPO Experience in process migration, is a plus. Fluency in the English language.
Creating a future worth living. For patients. Worldwide. Fresenius Medical Care is the world's leading provider of products and services for individuals with kidney disease of which approximately 4.5 million patients worldwide regularly undergo dialysis treatment. United by a shared purpose of creating a future worth living for chronically and critically ill people, we care for around 292,000 dialysis patients around the globe. In addition, we operate around 35 global production sites to provide products such as dialysis machines, dialyzers, and related disposables. We aim to continuously improve our patients’ quality of life by offering them high-quality products as well as innovative technologies and treatment concepts.